Drugs for COVID-19: An Update

23Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It caused the highly contagious disease called coronavirus disease 2019 (COVID-19), declared a global pandemic by the World Health Organization (WHO) on 11 March 2020. A great number of studies in the search of new therapies and vaccines have been carried out in these three long years, producing a series of successes; however, the need for more effective vaccines, therapies and other solutions is still being pursued. This review represents a tracking shot of the current pharmacological therapies used for the treatment of COVID-19.

Cite

CITATION STYLE

APA

Ceramella, J., Iacopetta, D., Sinicropi, M. S., Andreu, I., Mariconda, A., Saturnino, C., … Catalano, A. (2022, December 1). Drugs for COVID-19: An Update. Molecules. MDPI. https://doi.org/10.3390/molecules27238562

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free